VIEWPOINTS PharmaShots Interview: AstraZeneca’s Alexander Bedenkov Shares Insight on First Virtual Events with Slush to Improve Patients OutcomesBySenior EditorDecember 13, 20210Comments
VIEWPOINTS PharmaShots Interview: Entasis Therapeutics’s Manos Perros Shares Insight on the Data of Sulbactam-Durlobactam (SUL-DUR) for Carbapenem-Resistant Acinetobacter InfectionsBySenior EditorDecember 9, 20210Comments
VIEWPOINTS PharmaShots Interview: TFF Pharmaceuticals’s Glenn Mattes Shares Insights on the Thin Film Freezing TechnologyBySenior EditorDecember 8, 20210Comments
VIEWPOINTS PharmaShots Interview: Coral Genomics’s Atray Dixit Shares Insights on the 2021 Innovation Challenge in Inflammatory Bowel DiseaseBySenior EditorDecember 7, 20210Comments
VIEWPOINTS PharmaShots Interview: Medidata’s Ben Schlatka Shares Insights on Agreement with Labcorp to Advance the Use of Medical-Grade SensorsBySenior EditorDecember 6, 20210Comments
VIEWPOINTS PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune DiseaseBySenior EditorDecember 1, 20210Comments
VIEWPOINTS PharmaShots Interview: Vivacare’s Mark Becker Shares Insight on the Digital Patient Education Service for Allergic ConditionsBySenior EditorNovember 30, 20210Comments
VIEWPOINTS PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on the Data of Guardant360 Liquid Biopsy Test for the Treatment of Advanced Non-Small Cell Lung CancerBySenior EditorNovember 29, 20210Comments
